STAMFORD, Conn., May 27 /PRNewswire-FirstCall/ -- Zargis Medical
Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE),
today announced that it launched the live-streaming version of its
ZargisTelemed™ platform at last week's American Telemedicine
Association Conference (ATA) in San
Antonio, TX. The system allows healthcare professionals to
share stethoscope sounds in real-time with colleagues located
anywhere in the world through the Internet or a private network.
This technology is cleared for sale in the U.S. and 36 other
countries.
At ATA, Zargis demonstrated this new system to more than 100
interested healthcare organizations including the U.S. Veterans
Health Administration and other U.S. and foreign private and public
medical organizations. Zargis has delivered or is scheduled
to deliver trial versions of this system to eight telemedicine
groups for evaluation and has also signed a Letter of Intent with
one of the larger telemedicine organizations in the world.
This Letter of Intent requests that Zargis deliver sample
systems for formal evaluation. If the results of the
evaluation are satisfactory and the terms of the contract are
finalized, wide-scale implementation of Zargis' system is expected
to take place.
ZargisTelemed allows healthcare professionals to record, view
and transmit heart and lung sounds and can be deployed as a turnkey
enterprise server or accessed through Zargis' secure server. The
platform is designed to support the delivery of cost-effective,
expert healthcare to people in remote and rural locations by
extending the use of auscultation (listening with a stethoscope) to
situations and environments where face-to-face encounters are not
always feasible. The system is designed to be accessed from users'
PCs and is fully integrated with the award-winning Zargis
Cardioscan heart sounds analysis software and the Zargis
StethAssist™ heart and lung sounds visualization software.
The U.S. and Europe are the
dominant players in the worldwide telemedicine market, which is
expected to reach $18 billion by
2015, according to a 2009 report by Global Industry Analysts, Inc.,
a global business strategy company.
"The rapidly-growing demand for streamlined telehealth tools is
being driven by rising healthcare costs and the need to deliver
care to homebound patients as well as underserved populations in
remote and rural areas," stated Zargis CEO John Kallassy. "The ZargisTelemed system offers
healthcare practitioners around the world with an efficient and
highly cost-effective means to share and store stethoscope sounds
in a way that's never before been possible."
For more information about the ZargisTelemed system or to
arrange a demonstration, call 609-488-4608.
About Zargis Medical Corp.
Zargis is a global medical device company focused on improving
health outcomes and cost-effectiveness through diagnostic support
software and innovation. Zargis is majority-owned by Speedus
Corp. (Nasdaq: SPDE), and Siemens Corporate Research, a division of
Siemens AG (NYSE: SI), holds an equity position.
For additional information about Zargis or Speedus Corp.,
contact Peter Hodge at 888.773.3669
(ext. 23) or phodge@zargis.com, or visit the following Web sites:
www.zargis.com and www.speedus.com.
Statements contained herein that are not historical facts,
including but not limited to statements about the Company's
product, corporate identity and focus, may be forward-looking
statements that are subject to a variety of risks and
uncertainties. There are a number of important factors that could
cause actual results to differ materially from those expressed in
any forward-looking statements made by the Company, including, but
not limited to, the continuing development of the Company's sales,
marketing and support efforts.
SOURCE Speedus Corp.
